Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study - PubMed (original) (raw)
Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study
Enzo Bonora et al. Diabetes. 2004 Jul.
Abstract
Incidence rates and risk factors for type 2 diabetes in low-risk populations are not well documented. We investigated these in white individuals who were aged 40-79 years and from the population of Bruneck, Italy. Of an age- and sex-stratified random sample of 1,000 individuals who were identified in 1990, 919 underwent an oral glucose tolerance test (OGTT) and an assessment of physiological risk factors for diabetes, including insulin resistance (homeostasis model assessment, HOMA-IR), and postchallenge insulin response (Sluiter's Index). Diabetes at baseline by fasting or 2-h OGTT plasma glucose (World Health Organization criteria, n = 82) was excluded, leaving 837 individuals who were followed for 10 years. Incident cases of diabetes were ascertained by confirmed diabetes treatment or a fasting glucose >or=7.0 mmol/l. At follow-up, 64 individuals had developed diabetes, corresponding to a population-standardized incidence rate of 7.6 per 1,000 person-years. Sex- and age-adjusted incidence rates were elevated 11-fold in individuals with impaired fasting glucose at baseline, 4-fold in those with impaired glucose tolerance, 3-fold in overweight individuals, 10-fold in obese individuals, and approximately 2-fold in individuals with dyslipidemia or hypertension. Incidence rates increased with increasing HOMA-IR and decreasing Sluiter's Index. As compared with normal insulin sensitivity and normal insulin response, individuals with low insulin sensitivity and low insulin response had a sevenfold higher risk of diabetes. Baseline impaired fasting glucose, BMI, HOMA-IR, and Sluiter's Index were the only independent predictors of incident diabetes in multivariate analyses. We conclude that approximately 1% of European white individuals aged 40-79 years develop type 2 diabetes annually and that "subdiabetic" hyperglycemia, obesity, insulin resistance, and impaired insulin response to glucose are independent predictors of diabetes.
Similar articles
- Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity -- a problem that is no longer restricted to minority groups.
Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Grüters A. Wiegand S, et al. Eur J Endocrinol. 2004 Aug;151(2):199-206. doi: 10.1530/eje.0.1510199. Eur J Endocrinol. 2004. PMID: 15296475 - The homeostasis model in the San Antonio Heart Study.
Haffner SM, Miettinen H, Stern MP. Haffner SM, et al. Diabetes Care. 1997 Jul;20(7):1087-92. doi: 10.2337/diacare.20.7.1087. Diabetes Care. 1997. PMID: 9203442 - Glucose tolerance status in 510 children and adolescents attending an obesity clinic in Central Italy.
Brufani C, Ciampalini P, Grossi A, Fiori R, Fintini D, Tozzi A, Cappa M, Barbetti F. Brufani C, et al. Pediatr Diabetes. 2010 Feb;11(1):47-54. doi: 10.1111/j.1399-5448.2009.00527.x. Epub 2009 Apr 30. Pediatr Diabetes. 2010. PMID: 19460122 - [Prevalence of type II diabetes mellitus in population of Krakow].
Szurkowska M, Szybiński Z, Nazim A, Szafraniec K, Jedrychowski W. Szurkowska M, et al. Pol Arch Med Wewn. 2001 Sep;106(3):771-9. Pol Arch Med Wewn. 2001. PMID: 11928585 Clinical Trial. Polish. - Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC, Miranda WL, Chacra AR, Dib SA. da Silva RC, et al. J Diabetes Complications. 2007 Mar-Apr;21(2):84-92. doi: 10.1016/j.jdiacomp.2005.11.006. J Diabetes Complications. 2007. PMID: 17331856
Cited by
- Cardiometabolic Effects of Denosumab in Premenopausal Women With Breast Cancer Receiving Estradiol Suppression: RCT.
Ramchand SK, Hoermann R, White S, Yeo B, Francis PA, Xu CLH, Zajac JD, Seeman E, Grossmann M. Ramchand SK, et al. J Clin Endocrinol Metab. 2024 Sep 16;109(10):e1857-e1866. doi: 10.1210/clinem/dgae003. J Clin Endocrinol Metab. 2024. PMID: 38181438 Free PMC article. Clinical Trial. - Effect of denosumab on glucose metabolism in postmenopausal osteoporotic women with prediabetes: a study protocol for a 12-month multicenter, open-label, randomized controlled trial.
Wang Y, Jiang Y, Li J, Lin X, Luo Y, Tan S, Yang H, Gao Z, Cui X, Yin P, Kong D, Gao Y, Cheng Y, Zhang L, Tang P, Lyu H. Wang Y, et al. Trials. 2023 Dec 18;24(1):812. doi: 10.1186/s13063-023-07769-0. Trials. 2023. PMID: 38111052 Free PMC article. - Modelling the replacement of red and processed meat with plant-based alternatives and the estimated effect on insulin sensitivity in a cohort of Australian adults.
Goode JP, Smith KJ, Breslin M, Kilpatrick M, Dwyer T, Venn AJ, Magnussen CG. Goode JP, et al. Br J Nutr. 2024 Mar 28;131(6):1084-1094. doi: 10.1017/S0007114523002659. Epub 2023 Nov 20. Br J Nutr. 2024. PMID: 37981891 Free PMC article. - Elderly rats fed with a high-fat high-sucrose diet developed sex-dependent metabolic syndrome regardless of long-term metformin and liraglutide treatment.
Ivić V, Zjalić M, Blažetić S, Fenrich M, Labak I, Scitovski R, Szűcs KF, Ducza E, Tábi T, Bagamery F, Szökő É, Vuković R, Rončević A, Mandić D, Debeljak Ž, Berecki M, Balog M, Seres-Bokor A, Sztojkov-Ivanov A, Hajagos-Tóth J, Gajović S, Imširović A, Bakula M, Mahiiovych S, Gaspar R, Vari SG, Heffer M. Ivić V, et al. Front Endocrinol (Lausanne). 2023 Oct 20;14:1181064. doi: 10.3389/fendo.2023.1181064. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37929025 Free PMC article. - The Promising Frontier of Cardiometabolic Syndrome: A New Paradigm in Cardiology.
Khan AR, Salama AH, Aleem Z, Alfakeer H, Alnemr L, Shareef AMM. Khan AR, et al. Cureus. 2023 Sep 19;15(9):e45542. doi: 10.7759/cureus.45542. eCollection 2023 Sep. Cureus. 2023. PMID: 37868505 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials